206 related articles for article (PubMed ID: 12094959)
21. Altered mRNA expressions of sialyltransferases in ovarian cancers.
Wang PH; Lee WL; Juang CM; Yang YH; Lo WH; Lai CR; Hsieh SL; Yuan CC
Gynecol Oncol; 2005 Dec; 99(3):631-9. PubMed ID: 16112178
[TBL] [Abstract][Full Text] [Related]
22. Mouse beta-galactoside alpha 2,3-sialyltransferases: comparison of in vitro substrate specificities and tissue specific expression.
Kono M; Ohyama Y; Lee YC; Hamamoto T; Kojima N; Tsuji S
Glycobiology; 1997 Jun; 7(4):469-79. PubMed ID: 9184827
[TBL] [Abstract][Full Text] [Related]
23. The evolution of galactose alpha2,3-sialyltransferase: Ciona intestinalis ST3GAL I/II and Takifugu rubripes ST3GAL II sialylate Galbeta1,3GalNAc structures on glycoproteins but not glycolipids.
Lehmann F; Kelm S; Dietz F; von Itzstein M; Tiralongo J
Glycoconj J; 2008 May; 25(4):323-34. PubMed ID: 17973185
[TBL] [Abstract][Full Text] [Related]
24. A novel viral alpha2,3-sialyltransferase (v-ST3Gal I): transfer of sialic acid to fucosylated acceptors.
Sujino K; Jackson RJ; Chan NW; Tsuji S; Palcic MM
Glycobiology; 2000 Mar; 10(3):313-20. PubMed ID: 10704530
[TBL] [Abstract][Full Text] [Related]
25. A rapid, semi-automated method for detection of Galbeta1-4GlcNAc alpha2,6-sialyltransferase (EC 2.4.99.1) activity using the lectin Sambucus nigra agglutinin.
Halliday JA; Franks AH; Ramsdale TE; Martin R; Palant E
Glycobiology; 2001 Jul; 11(7):557-64. PubMed ID: 11447135
[TBL] [Abstract][Full Text] [Related]
26. Genetic engineering of CHO cells producing human interferon-gamma by transfection of sialyltransferases.
Fukuta K; Yokomatsu T; Abe R; Asanagi M; Makino T
Glycoconj J; 2000 Dec; 17(12):895-904. PubMed ID: 11511814
[TBL] [Abstract][Full Text] [Related]
27. A systematic analysis of acceptor specificity and reaction kinetics of five human α(2,3)sialyltransferases: Product inhibition studies illustrate reaction mechanism for ST3Gal-I.
Gupta R; Matta KL; Neelamegham S
Biochem Biophys Res Commun; 2016 Jan; 469(3):606-12. PubMed ID: 26692484
[TBL] [Abstract][Full Text] [Related]
28. Cloning, expression and gene organization of a human Neu5Ac alpha 2-3Gal beta 1-3GalNAc alpha 2,6-sialyltransferase: hST6GalNAcIV.
Harduin-Lepers A; Stokes DC; Steelant WF; Samyn-Petit B; Krzewinski-Recchi MA; Vallejo-Ruiz V; Zanetta JP; Augé C; Delannoy P
Biochem J; 2000 Nov; 352 Pt 1(Pt 1):37-48. PubMed ID: 11062056
[TBL] [Abstract][Full Text] [Related]
29. Characterization of mouse sialyltransferase genes: their evolution and diversity.
Takashima S
Biosci Biotechnol Biochem; 2008 May; 72(5):1155-67. PubMed ID: 18460788
[TBL] [Abstract][Full Text] [Related]
30. Sialylation of E-cadherin does not change the spontaneous or ET-18-OMe-mediated aggregation of MCF-7 human breast cancer cells.
Steelant WF; Recchi MA; Noë VT; Boilly-Marer Y; Bruyneel EA; Verbert A; Mareel MM; Delannoy P
Clin Exp Metastasis; 1999 May; 17(3):245-53. PubMed ID: 10432010
[TBL] [Abstract][Full Text] [Related]
31. The pattern of glycosyl- and sulfotransferase activities in cancer cell lines: a predictor of individual cancer-associated distinct carbohydrate structures for the structural identification of signature glycans.
Chandrasekaran EV; Xue J; Neelamegham S; Matta KL
Carbohydr Res; 2006 Jun; 341(8):983-94. PubMed ID: 16545347
[TBL] [Abstract][Full Text] [Related]
32. Functions of Sialyltransferases in gynecological malignancies: A systematic review.
Sun S; Yang Z; Majdaeen M; Agbele AT; Abedi-Firouzjah R
Pathol Res Pract; 2024 Feb; 254():155159. PubMed ID: 38306862
[TBL] [Abstract][Full Text] [Related]
33. Sialyltransferases of developing rat brain.
Dall'Olio F
Glycoconj J; 1990; 7(4):301-10. PubMed ID: 1726633
[TBL] [Abstract][Full Text] [Related]
34. Biosynthesis of the O-glycosidically linked oligosaccharide chains of fetuin. Indications for an alpha-N-acetylgalactosaminide alpha 2 leads to 6 sialyltransferase with a narrow acceptor specificity in fetal calf liver.
Bergh ML; Hooghwinkel GJ; van den Eijnden DH
J Biol Chem; 1983 Jun; 258(12):7430-6. PubMed ID: 6190802
[TBL] [Abstract][Full Text] [Related]
35. ST3Gal III modulates breast cancer cell adhesion and invasion by altering the expression of invasion-related molecules.
Cui HX; Wang H; Wang Y; Song J; Tian H; Xia C; Shen Y
Oncol Rep; 2016 Dec; 36(6):3317-3324. PubMed ID: 27779707
[TBL] [Abstract][Full Text] [Related]
36. CMP substitutions preferentially inhibit polysialic acid synthesis.
Miyazaki T; Angata K; Seeberger PH; Hindsgaul O; Fukuda M
Glycobiology; 2008 Feb; 18(2):187-94. PubMed ID: 18077550
[TBL] [Abstract][Full Text] [Related]
37. Alpha2,6-sialylation of cell-surface N-glycans inhibits glioma formation in vivo.
Yamamoto H; Oviedo A; Sweeley C; Saito T; Moskal JR
Cancer Res; 2001 Sep; 61(18):6822-9. PubMed ID: 11559557
[TBL] [Abstract][Full Text] [Related]
38. Purification of a Gal beta 1 to 4GlcNAc alpha 2 to 6 sialyltransferase and a Gal beta 1 to 3(4)GlcNAc alpha 2 to 3 sialyltransferase to homogeneity from rat liver.
Weinstein J; de Souza-e-Silva U; Paulson JC
J Biol Chem; 1982 Nov; 257(22):13835-44. PubMed ID: 7142179
[TBL] [Abstract][Full Text] [Related]
39. Human colon cancer cell lines permanently expressing alpha 2,6-sialylated sugar chains by transfection with rat beta-galactoside alpha 2,6 sialyltransferase cDNA.
Dall'Olio F; Chiricolo M; Lollini P; Lau JT
Biochem Biophys Res Commun; 1995 Jun; 211(2):554-61. PubMed ID: 7794269
[TBL] [Abstract][Full Text] [Related]
40. α2,3-Sialyltransferase ST3Gal IV promotes migration and metastasis in pancreatic adenocarcinoma cells and tends to be highly expressed in pancreatic adenocarcinoma tissues.
Pérez-Garay M; Arteta B; Llop E; Cobler L; Pagès L; Ortiz R; Ferri MJ; de Bolós C; Figueras J; de Llorens R; Vidal-Vanaclocha F; Peracaula R
Int J Biochem Cell Biol; 2013 Aug; 45(8):1748-57. PubMed ID: 23726834
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
